{"transactions":[{"id":2797877,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2021-03-10T22:38:31.000Z","date":"2021-03-08","kind":"tax_withholding","acquired":false,"shares":5221,"price":33.37,"value":174224.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":147346,"source":{"system":"sec-edgar","filing":"0001209191-21-019555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121019555/doc4.xml","form_type":"4"}},{"id":2830766,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-27T00:25:59.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":39900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years."}],"balance_after":39900,"derivative":{"exercise_price":53.01,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":39900},"source":{"system":"sec-edgar","filing":"0001209191-21-015010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121015010/doc4.xml","form_type":"4"}},{"id":2830765,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2021-02-27T00:25:59.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":20800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years."}],"balance_after":152567,"source":{"system":"sec-edgar","filing":"0001209191-21-015010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121015010/doc4.xml","form_type":"4"}},{"id":2952412,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2020-12-10T00:33:23.000Z","date":"2020-12-07","kind":"tax_withholding","acquired":false,"shares":2728,"price":41.99,"value":114548.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":131767,"source":{"system":"sec-edgar","filing":"0001209191-20-062619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120062619/doc4.xml","form_type":"4"}},{"id":2973692,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T21:52:22.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":7082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.575,"expiration_date":"2024-03-19","underlying":"Common Stock","underlying_shares":7082},"source":{"system":"sec-edgar","filing":"0001209191-20-059427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120059427/doc4.xml","form_type":"4"}},{"id":2973691,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2020-11-19T21:52:22.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":7082,"price":14.575,"value":103220.15,"ownership":{"direct":true},"balance_after":134495,"source":{"system":"sec-edgar","filing":"0001209191-20-059427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120059427/doc4.xml","form_type":"4"}},{"id":3034797,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2020-09-10T23:32:58.000Z","date":"2020-09-08","kind":"tax_withholding","acquired":false,"shares":2728,"price":42.16,"value":115012.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":127413,"source":{"system":"sec-edgar","filing":"0001209191-20-050049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120050049/doc4.xml","form_type":"4"}},{"id":3115283,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2020-06-10T23:45:23.000Z","date":"2020-06-08","kind":"tax_withholding","acquired":false,"shares":2728,"price":33.61,"value":91688.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":130141,"source":{"system":"sec-edgar","filing":"0001209191-20-035694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120035694/doc4.xml","form_type":"4"}},{"id":3203391,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-19T00:03:09.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent of the shares subject to the option vests March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years."}],"balance_after":62500,"derivative":{"exercise_price":26.41,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-20-020121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120020121/doc4.xml","form_type":"4"}},{"id":3203390,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2020-03-19T00:03:09.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years."}],"balance_after":132191,"source":{"system":"sec-edgar","filing":"0001209191-20-020121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120020121/doc4.xml","form_type":"4"}},{"id":3203389,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2020-03-19T00:03:09.000Z","date":"2020-03-06","kind":"tax_withholding","acquired":false,"shares":6525,"price":39.71,"value":259107.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":94691,"source":{"system":"sec-edgar","filing":"0001209191-20-020121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120020121/doc4.xml","form_type":"4"}},{"id":3348694,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2019-12-10T01:13:06.000Z","date":"2019-12-06","kind":"tax_withholding","acquired":false,"shares":2442,"price":47.39,"value":115726.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":101216,"source":{"system":"sec-edgar","filing":"0001209191-19-059778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919119059778/doc4.xml","form_type":"4"}},{"id":3418868,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2019-09-11T00:31:21.000Z","date":"2019-09-06","kind":"tax_withholding","acquired":false,"shares":5541,"price":41.68,"value":230948.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":103658,"source":{"system":"sec-edgar","filing":"0001209191-19-049100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919119049100/doc4.xml","form_type":"4"}},{"id":3472547,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2019-07-03T00:11:39.000Z","date":"2019-06-28","kind":"sale","acquired":false,"shares":2873,"price":45,"value":129285.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan."}],"balance_after":109199,"source":{"system":"sec-edgar","filing":"0001209191-19-040581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919119040581/doc4.xml","form_type":"4"}},{"id":3483168,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T22:19:44.000Z","date":"2019-06-18","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":7082,"derivative":{"exercise_price":14.575,"expiration_date":"2024-03-19","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-19-038295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919119038295/doc4.xml","form_type":"4"}},{"id":3483167,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2019-06-20T22:19:44.000Z","date":"2019-06-18","kind":"exercise","acquired":true,"shares":16000,"price":14.575,"value":233200.0,"ownership":{"direct":true},"balance_after":112072,"source":{"system":"sec-edgar","filing":"0001209191-19-038295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919119038295/doc4.xml","form_type":"4"}},{"id":3497795,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":141563,"kind":"person","name":"Kouchakji Elias","position":1,"cik":"0001775259","reported_name":"Kouchakji Elias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Dev, Drug Safety"}}],"security":"Common Stock","published_at":"2019-06-07T23:36:20.000Z","date":"2019-06-06","kind":"tax_withholding","acquired":false,"shares":2058,"price":38.31,"value":78841.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 618 shares acquired on May 15, 2019 through the Issuer's Employee Stock Purchase Plan."}],"balance_after":96072,"source":{"system":"sec-edgar","filing":"0001209191-19-035678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919119035678/doc4.xml","form_type":"4"}}]}